Samsara BioCapital as of March 31, 2019
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 18 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals In | 18.6 | $24M | 211k | 111.86 | |
| Allakos | 14.2 | $18M | 447k | 40.50 | |
| Odonate Therapeutics Ord | 10.3 | $13M | 596k | 22.11 | |
| Principia Biopharma | 10.2 | $13M | 384k | 34.00 | |
| Sutro Biopharma (STRO) | 10.1 | $13M | 1.1M | 11.39 | |
| Gossamer Bio (GOSS) | 9.1 | $12M | 533k | 21.67 | |
| Syros Pharmaceuticals | 7.6 | $9.7M | 1.1M | 9.14 | |
| Liquidia Technologies (LQDA) | 5.7 | $7.3M | 639k | 11.38 | |
| Sunesis Pharmaceuticals Inc Ne | 3.6 | $4.5M | 3.8M | 1.21 | |
| Kalvista Pharmaceuticals (KALV) | 2.7 | $3.4M | 119k | 28.62 | |
| Aravive | 2.5 | $3.1M | 443k | 7.04 | |
| Catabasis Pharmaceuticals Ord | 1.9 | $2.4M | 300k | 7.92 | |
| Evelo Biosciences | 1.4 | $1.8M | 228k | 8.00 | |
| Urovant Sciences | 1.2 | $1.6M | 158k | 10.05 | |
| Millendo Therapeutics | 0.5 | $677k | 45k | 15.01 | |
| Surface Oncology | 0.3 | $373k | 78k | 4.76 | |
| Pds Biotechnology Ord (PDSB) | 0.1 | $68k | 9.2k | 7.42 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $47k | 72k | 0.66 |
